Chemetall expansion to double lithium production capacity

Published: 7-Feb-2012
Ingredients Hi Tech Manufacturing Finance

Firm invests a total of US$215m in Chile and US


Chemetall Lithium Division, part of Rockwood Holdings, is investing US$140m in a new lithium carbonate production plant in Chile.

The new investment, along with the company’s current $75m (€163m) expansion programme in the US, will increase total annual production capacity to 50,000 metric tons of lithium carbonate by the end of 2013.

The Frankfurt, Germany-based manufacturer of lithium specialities and lithium compounds plans to build a 20,000 metric ton lithium carbonate plant at LeNegra, near the port of Antofagasta in northern Chile.

Chemetall is currently completing the expansion of its brine pond system at Silver Peak, NV and the construction of a battery grade lithium hydroxide plant and a global technical centre at Kings Mountain, NC. These expanded sites in the US will be on stream this spring.

Steffen Haber, president of Rockwood's Lithium division said the investment will make it possible for Chemetall to develop and produce new grades of high purity lithium compounds that are required for applications such as batteries, pharmaceuticals and lithium alloy.

  • Companies:
  • Rockwood Lithium
See more

You may also like

Ingredients

Penn Specialty Chemicals and Chemetall join forces in marketing organometallic reagents

Read more
US company Penn Specialty Chemicals, of Philadelphia, has joined forces with Chemetall, of Frankfurt, Germany in a strategic marketing agreement for global market development of the solvent MeTHF (2-methyltetrahydrofuran) and MeTHF soluble organometallic reagents, organic and inorganic salts, hydrides and alcoxides.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  2. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  3. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Ingredients

Penn Specialty Chemicals and Chemetall join forces in marketing organometallic reagents

<p>US company Penn Specialty Chemicals, of Philadelphia, has joined forces with Chemetall, of Frankfurt, Germany in a strategic marketing agreement for global market development of the solvent MeTHF (2-methyltetrahydrofuran) and MeTHF soluble organometallic reagents, organic and inorganic salts, hydrides and alcoxides.</p>
Finance

Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China

New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
Finance

Newcells Biotech raises additional funding from investors

Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
Manufacturing

ACG expands global footprint with new capsule manufacturing facility in Thailand

New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
Finance

Novo Holdings completes acquisition of Catalent

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535

Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
Manufacturing

£20m Scottish oligonucleotide manufacturing innovation centre now under construction

The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence
Subscribe now